New interdisciplinary research program in biomedical innovation law

(University of Copenhagen, Faculty of Law) The Novo Nordisk Foundation has awarded a grant of DKK 35 million to Timo Minssen, Professor, Faculty of Law, University of Copenhagen for establishing a Collaborative Research Programme in Biomedical Innova-tion Law (CeBIL).The aim of CeBIL is to analyse the most important legal obstacles to pharmaceutical innovation and thereby contribute to translating innova-tive biomedical research into new effective, affordable and easily acces-sible forms of treatment.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news